<DOC>
	<DOCNO>NCT02614534</DOCNO>
	<brief_summary>The purpose study determine whether Hyperthermic Intra-peritoneal Chemotherapy ( HIPEC ) Mitomycin C use surgery treatment locally advance colorectal carcinoma effective treatment locally advance colorectal carcinoma .</brief_summary>
	<brief_title>Clinical Trial Evaluate Safety Efficacy Hyperthermic Intra-peritoneal Chemotherapy ( HIPEC ) With Mitomycin C Used During Surgery Treatment Locally Advanced Colorectal Carcinoma</brief_title>
	<detailed_description>The purpose study determine whether Hyperthermic Intra-peritoneal Chemotherapy ( HIPEC ) Mitomycin C use surgery treatment locally advance colorectal carcinoma effective treatment locally advance colorectal carcinoma . The Hyperthermic Intra-peritoneal Chemotherapy ( HIPEC ) expect effective treatment minimal side effect , already provide clear benefit term overall survival patient advance cancer . This attractive option healthcare professional face daily peritoneal recurrence perform complex surgery , however application difficult due cost resource increase . This lead necessity administer treatment within clinical trial order obtain significant power clinical trial multicenter perform several Oncological surgery Units highly specialise extensive experience colorectal carcinoma .</detailed_description>
	<mesh_term>Colorectal Neoplasms</mesh_term>
	<mesh_term>Fever</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<criteria>1 . Male female patient age 18 75 year ; 2 . Adenocarcinoma colon , sigma colonsigma joint represent cT4a/b line The American Joint Committee Cancer : 7th edition AJCC cancer stag manual ; 3 . Lymph node involvement : N0 , presence N1/2 accord 7th edition AJCC allow , provide resectable ; 4 . Metastatic extent : M0 ; 5 . Karnofsky index &gt; 70 Performance status â‰¤2 ; 6 . Informed consent properly complete . 1 . Presence metastasis ( M1 ) ; 2 . Presence unresectability criterion ; 3 . Urgent intervention obstruction perforation ; 4 . Extraperitoneal rectal cancer ( avoid alteration neoadyuvance ) ; 5 . Coexistence another malignant neoplastic disease ; 6 . Severely altered liver , kidney cardiovascular function ; 7 . Intolerance treatment ; 8 . Administration chemotherapy trial ( use neoadyuvance discard ) ; 9 . Pregnant breastfeed woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>